Supplementary Figure 3 from Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions

Won Young Tak,Shi‐Ming Lin, Yijun Wang, Jingwu Zheng, Andrea Vecchione,Soo Young Park,Min Hua Chen, Stephen T.C. Wong, Ruocai Xu,Cheng Yuan Peng,Yi–You Chiou,Guan‐Tarn Huang,Jianqiang Cai, Basri Johan Jeet Abdullah,June Sung Lee,Jae Young Lee,Jong-Young Choi, Julieta Gopez-Cervantes,Morris Sherman,Richard S. Finn,Masao Omata, Michael O’Neal,Lukas Makris, Nicholas J. Borys,Ronnie Tung‐Ping Poon,Riccardo Lencioni

openalex（2023）

引用 0|浏览8

暂无评分

摘要

Supplementary Figure 3: Forest Plot of Hazard Ratio of Treatment Effect on Progression-Free Survival, According to Baseline Prognostic Factors. (A) Intent-to-treat population, n=701; (B) Subset: Solitary lesion (BCLC A) and RFA dwell time {greater than or equal to}45 min, n=285.

查看译文

关键词

unresectable hepatocellular carcinoma lesions,radiofrequency ablation,hepatocellular carcinoma,lyso-thermosensitive

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要